Nikhil Hanmantgad

Managing Director

Location: New York

Nikhil joined BCI in 2025 as Managing Director with the Private Equity team based in New York and helps lead the global Healthcare team. He is responsible for executing the healthcare sector strategy including deal origination, transaction execution, value creation initiatives, and portfolio company engagement. With $295 billion in assets under management as of March 31, 2025, BCI is one of the largest institutional investors in Canada.

Nikhil brings two decades of deep healthcare investing and operating experience. He has led the execution of $2.5 billion in invested capital across growth equity and buy-outs of healthcare businesses in his career. Most recently, he helped lead the U.S. healthcare private equity investing team as a senior leader of the New York office at Mubadala, a $330 billion UAE sovereign wealth fund. Prior to Mubadala, Nikhil was a senior professional and a member of the Investment Committee at HCC, a lower-middle-market healthcare private equity fund. Prior to HCC, Nikhil was the CEO of MedTools, a healthcare IT business driving improved access and utility of information on medical devices for surgeons and hospital procurement departments. Previously, Nikhil was an Associate in the healthcare group at Goldman Sachs where he focused on the medical devices sector and started his career as an Analyst in the healthcare group at Citigroup where he focused on the healthcare insurance sector.

Nikhil holds an MBA from Columbia University Graduate School of Business and a Bachelor of Science in Finance from New York University Stern School of Business. Nikhil also served as a member of the board of directors and on various committees of portfolio companies including driving several successful exits.